SAFETY (REPORTING) In accordance with the guidelines of ICH-GCP, the European Clinical Trials Directive (2001/20/EC) and the local regulations, the investigator will inform the subjects and the reviewing Ethical Review Board (ERB) if anything occurs, on the basis of which it appears that the disadvantages of participation may be significantly greater than was foreseen in the research proposal.